Indian Navy Medical Supplies Tender Mumbai Maharashtra 2026 - 83-item Pharmaceutical & Consumable Procurement

Tender Overview

The Indian Navy, Department of Military Affairs, seeks procurement of a wide range of pharmaceutical products and related consumables in Mumbai, Maharashtra. Estimated value is about ₹101,091.00, with no explicit EMD amount published. The bid targets medical formulations, injections, syrups, oral rehydration sachets, eye drops, ointments, IV sets, and related items across 53 listed BOQ entries. This tender emphasizes compliance with bidder turnover criteria and GST considerations, while indicating inspection by SLBR52 as part of quality checks. The overarching objective is to equip naval medical facilities with a diverse, ready-to-use inventory, leveraging standard procurement processes under GEM platform guidelines. The basket includes antibiotics, analgesics, antiemetics, antihistamines, vitamins, fluids, and first-aid consumables, underscoring a broad clinical support scope. Unique aspects include the extensive catalog of items and the requirement for documented financial stability through three-year turnover evidence. This opportunity targets pharmaceutical distributors and medical supply contractors capable of delivering a comprehensive mix of products to Mumbai-based facilities.

Technical Specifications & Requirements

• Product categories include: Diclofenac 25mg/ml IP 3ml Inj, Cetirizine Dihydrochloride 10 mg Tab, Hydrocortisone Sodium Succinate 100 mg Inj, Clopidogrel 75 mg Tab, Hydrogen peroxide solution, Pantoprazole 40 mg Inj, Sucralfate Suspension, Norfloxacin + Tinidazole Tab, Oral Rehydration powder sachet, Dicyclomine HCl + Paracetamol Tab, Ascorbic Acid 500 mg Tab, Vitamin B complex (B1 5 mg, B6 3 mg, B12 5 mcg), Doxycycline 100 mg cap, Norfloxacin 400 mg Tab, Albendazole Syrup, Betamethasone Dipropionate, Gentamycin, Povidone Iodine, Lactic acid Bacillus Sporlac, Hyoscine Bromide Inj, Loperamide, Ondansetron, Cetrizine Syrup, Ondansetron Syrup, IV infusion kit, Ciprofloxacin eye drops, Luliconazole cream, Betahistine, Cough syrup, Diclofenac gel, Fexofenadine, Endotracheal tubes, disposable syringes, bandages, cotton wool, gauze, skin stapler, and Vitamin B complex variants.
• No detailed technical specifications are published in the BOQ; bidders should interpret item names as the procurement scope and prepare accordingly.
• Delivery and inspection terms reference SLBR52; no explicit warranty, testing metrics, or ISO/IS specifications are listed in the tender data.
• Estimated value signals broad, multi-product medical supply provisioning, implying need for broad supplier capability and timely Mumbai delivery capabilities.

Terms, Conditions & Eligibility

• Turnover criteria: Average annual financial turnover in the last 3 years must meet the value stated in the bid document; provide certified audited balance sheets or CA certificate showing turnover details; for new entities, turnover for completed years after constitution is considered.
• GST consideration: Bidder must account for applicable GST; reimbursement as per actuals or applicable rates, whichever is lower, within quoted GST percentage.
• Inspection: Bid evaluation includes inspection per internal process (e.g., SLBR52); no explicit warranty period or penalty terms listed in the data.
• Documentation readiness: Prepare financials, turnover certificates, and audit reports; ensure statutory compliance documentation accompanies bid submission.
• Delivery implications: No explicit delivery schedule published; bidders should assume standard GEM timelines and Mumbai-based delivery readiness.
• EMD details: Not specified in the tender data; bidders should monitor GEM portal for exact EMD instructions.